Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-950-4 | CAS number: 3290-92-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Carcinogenicity
Administrative data
Description of key information
No clinical signs or adverse histological changes were observed in male mice treated with after 80-weeks dermal exposure.
No carcinogenic effect of trimethylolpropane trimethacrylate was observed in male mice after a 80-week dermal exposure in this study.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Link to relevant study records
- Endpoint:
- carcinogenicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The purpose of this investigation was to assess the carcinogenic potentialof substances in the classical mouse skin bioassay. In addition, the study also provided information about the chronic dermal toxicity of substance.
- GLP compliance:
- yes
- Species:
- mouse
- Strain:
- C3H
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Jackson Laboratory, Bar Harbor, Maine
- Age at study initiation: 6-8 weeks old
- Weight at study initiation: no data
- Fasting period before study: no data
- Housing: 5 animals in stainless steel suspended cages.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 2 weeks
Mice manifesting any signs of morbidity during the quarantine period were not included in the experiment.
ENVIRONMENTAL CONDITIONS: no data - Route of administration:
- dermal
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Before starting treatments, mice were weighed and their backs shaved with electric clippers. Their backs were also shaved biweekly.
The materials were applied to the interscapular region of the shaven backs on the surface of the skin grew to 1 mm3. - Duration of treatment / exposure:
- 80 weeks
- Frequency of treatment:
- twice per week
- Remarks:
- Doses / Concentrations:
25 mg/mice
Basis:
nominal conc. - No. of animals per sex per dose:
- 50 mice/dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: Before initiating the long-term bioassay, a pilot study was conducted to find a suitable dose and solvent.
In the acute pilot study, five mice were exposed to 50 mg of undiluted test substance. No clinical signs or mortalities were observed after treatment (3-days of observation).
In the first dilution study, three mice were exposed to 50 mg twice week to 10% test substance in acetone during two weeks. A very sightly epilated was observed.
In the second dilution study, three mice were exposed to 25 mg twice week to undiluted test substance during 4 weeks. No toxic signs were observed.
- Rationale for animal assignment : random
- Rationale for selecting satellite groups: no satellite group - Positive control:
- yes: 0.05% benzo(a)pyrene in mineral oil. 50 mg twice week.
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS and DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
DERMAL IRRITATION (if dermal study): Yes
BODY WEIGHT: Yes
- Time schedule for examinations: before first treatment, and weekly during the first month, thereafter every two weeks.
FOOD CONSUMPTION: no data
WATER CONSUMPTION: no data
OPHTHALMOSCOPIC EXAMINATION: no data
HAEMATOLOGY: no data
CLINICAL CHEMISTRY: no data
URINALYSIS: no data
NEUROBEHAVIOURAL EXAMINATION: no data - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Complete histological examinations was performed on 10% of the treated mice, and 100% of untreated mice.
At autopsy, all skin neoplasms were measured and recorded on a necropsy sheet. The interscapular area was dissected as one rectangular piece of skin. This section included all neoplasms and suspicions lesions. After removal, this section od skin was spread on a piece of filter paper and submerged in neutral formalin. The subcutaneous lymph nodes from the neck, axillary and groin areas were dissected out, placed in ambedding bags, and immersed in fixative. The abdominal, chest and cranial cavities were examined. All organs were removed and any abnormalities were recorded. Tissue from each organ was preserved in neutral formalin for possible microscopic examination.
On animals that died or those sacrified because of moribond condition, a complete post mortem examination was performed. - Other examinations:
- no
- Statistics:
- no
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- Five mice died during the study on days 10, 39, 55, 57 and 65. Tissues of these mice were not saved.
Four mice were sacrified before the end of the study on days 39, 59, 68 and 71 ; the cause of the sacrifice was not detailed. All the other mice were sacrified between days 78 and 84. - Body weight and weight changes:
- not specified
- Description (incidence and severity):
- At the beginning of the study, mice weighed approximately 25 g.
A slight decrease of body weight was observed in the two first days after first application. Thereafter the bodyweight inscreased to attain 29-30g at week 35. A decrease of body weight was observed at the end of the study (after the week 75). - Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- No gross observation of skin was observed in the treated and control animals.
The skin non-neoplasic lesions observed in the treated animals: ulcer (1/46 mice), acanthosis (46/46 mice), fibrosis (24/46), and hyperkeratosis (2/46).
Acanthosis and fibrosis were chemically and/or mechanically induced. Both lesions were observed in non-treated animals (acanthosis: 43/48, fibrosis:31/48). Ulcer (7/48), abscess (1/48), dysplasia (1/48) were observed in non-treated mice. - Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Pathologic lesions observed in the treated animals: lung (pneumonia, 1/4 mice), liver (carcinoma, 1/4 ; necrosis, 1/4; but not the same animal), lymphadentitis (2/4).
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- No skin tumors were present in mice treated with trimethylolpropane trimethacrylate. One mouse in the "no treatment" group had a squamous cell carcinoma.
- Relevance of carcinogenic effects / potential:
- No carcinogenic effect of trimethylolpropane trimethacrylate was observed in male mice after 80-week dermal exposure in this study.
- Dose descriptor:
- NOAEL
- Remarks:
- (systemic toxicity)
- Effect level:
- 25 other: mg/mice
- Sex:
- male
- Basis for effect level:
- body weight and weight gain
- clinical signs
- mortality
- Dose descriptor:
- NOAEL
- Remarks:
- (carcinogenicity)
- Effect level:
- 25 other: mg/mice
- Sex:
- male
- Basis for effect level:
- histopathology: neoplastic
- Conclusions:
- No clinical signs or adverse histological changes were observed in male mice treated with after a 80-week dermal exposure.
- Executive summary:
The purpose of this investigation was to assess the carcinogenic potentialof substances in the classical mouse skin bioassay. In addition, the study also provided information about the chronic dermal toxicity of substance.
Group of 25 mice were exposed to 25 mg of TMPTMA by animal by day, corresponding to 833 mg/kg bw/d, twice weekly during 80 weeks. A control group of 25 mice were not treated. Nine mice died or was sacrified during the study. There were no data on clinical signs. A slight decrease of body weight was observed in the two first days after first application. Thereafter the bodyweight increased to attain 29-30g at week 35. A decrease of body weight was observed at the end of the study (after the week 75).
No gross observation of skin was observed in the treated and control animals. The skin non-neoplasic lesions observed in the treated animals were ulcer (1/46 mice), acanthosis (46/46 mice), fibrosis (24/46), and hyperkeratosis (2/46). Acanthosis and fibrosis were chemically and/or mechanically induced. Both lesions were observed in non-treated animals (acanthosis: 43/48, fibrosis:31/48). Ulcer (7/48), abscess (1/48), dysplasia (1/48) were also observed in non-treated mice.
Pathologic lesions were observed in the treated animals: on lung (pneumonia, 1/4 mice), liver (carcinoma, 1/4 ; necrosis, 1/4; but not the same animal) and lymphadentitis (2/4). No skin tumors were present in mice treated with trimethylolpropane trimethacrylate. One mouse in the "no treatment" group had a squamous cell carcinoma.
Reference
Description of pathologic lesions of the skin:
-Acanthosis: A thickening of the epidermis caused by an increase in the number of cells of the stratum granulosum.
-Fibrosis: A thinckening of the dermis caused by an increase of collagenous fibrous tissue.
-Hyperkeratosis: A piling up of the stratum corneum epidermidis.
-Ulcer: A defect in the epidermis and part of dermis. Inflammatory infiltration by lymphocytes and macrophages is present in the dermal tissue. Granulation tissue may cover the base of the deflect.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 833 mg/kg bw/day
- Study duration:
- chronic
- Species:
- mouse
- Quality of whole database:
- Barkley's study was considered to be reliable.
Justification for classification or non-classification
Based on the results of the dermal carcinogenicity study, no classification is required for TMPTMA according to the CLP Regulation (EC) N° 1272-2008.
Additional information
80 -week carcinogenicity study on mouse by dermal route (University of Cincinnati Medical Center, 1982):
The purpose of this investigation was to assess the carcinogenic potential of substances in the classical mouse skin bioassay. In addition, the study also provided information about the chronic dermal toxicity of substance.
Group of 25 mice were exposed to 25 mg of TMPTMA by animal by day, corresponding to 833 mg/kg bw/d, twice weekly during 80 weeks. A control group of 25 mice were not treated. Nine mice died or was sacrified during the study. There were no data on clinical signs. A slight decrease of body weight was observed in the two first days after first application. Thereafter the bodyweight increased to attain 29-30g at week 35. A decrease of body weight was observed at the end of the study (after the week 75).
No gross observation of skin was observed in the treated and control animals. The skin non-neoplasic lesions observed in the treated animals were ulcer (1/46 mice), acanthosis (46/46 mice), fibrosis (24/46), and hyperkeratosis (2/46). Acanthosis and fibrosis were chemically and/or mechanically induced. Both lesions were observed in non-treated animals (acanthosis: 43/48, fibrosis:31/48). Ulcer (7/48), abscess (1/48), dysplasia (1/48) were also observed in non-treated mice.
Pathologic lesions were observed in the treated animals: on lung (pneumonia, 1/4 mice), liver (carcinoma, 1/4 ; necrosis, 1/4; but not the same animal) and lymphadentitis (2/4). No skin tumors were present in mice treated with trimethylolpropane trimethacrylate. One mouse in the "no treatment" group had a squamous cell carcinoma.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)